Developmental animal model of temporal lobe epilepsy

Multicellular living organisms and unmodified parts thereof and – Nonhuman animal – The nonhuman animal is a model for human disease

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C800S014000

Reexamination Certificate

active

07034201

ABSTRACT:
Disclosed is a developmental animal model of temporal lobe epilepsy and other seizure-related disorders. In particular, the invention provides a method of inducing a permanent change in the neurological development of a rodent, such as a rat, comprising daily administration of low doses of a kainate receptor agonist to the animal in the second postnatal week, wherein after treatment with the kainate receptor agonist the animal exhibits reproducible seizure-like symptoms when exposed to mild to moderate stressors. Rats treated using the above method are particularly useful as a non-human system for studying temporal lobe epilepsy, as well as for studying the efficacy of potential anti-epileptic compounds and pharmaceutical preparations.

REFERENCES:
patent: 5549884 (1996-08-01), Weinberger et al.
patent: 5698766 (1997-12-01), Julius et al.
patent: 2002/0104107 (2002-08-01), Lester et al.
Ruscheweyh, et al., 2000, Brain Research Reviews, 40: 215-222.
Clarke, et al., 1997, Nature, 389: 599-603.
Johansen et al., 2003, Chirality, 15: 167-179.
Khalilov et al. 2002, J. Neurophysiolo., 88:523-527.
Tracy A. Doucette, Paul B. Bernard, P. Corrinne Yuill, R. Andrew Tasker, Catherine L. Ryan; Low doses of non-NMDA glutamate receptor agonists alter neurobehavioural development in the rat; Neurotoxicology and Teratology 25 (2003) 473-479.
M.A. Perry, A.R. Tasker, C.L. Ryan; The Effects Of Low Doses of Domoic Acid and Kaimic Acid On Neuroendocrine Regulation In The Rat; Abstract View Program No. 614.7/Intinerary Planner, Wash. D.C. Society for Neuroscience, 2003/Online.
P.B. Bernard, T.A. Doucette, C.L. Ryan, R. Tasker; Cytoarchitectual Changes In The Developing Hippocampus Following Administration Of A Kainate Receptor Agonist; Abstract View, Program No. 218.3/Intinerary Planner, Wash. D.C. Society for Neuroscience, 2003/Online.
T.A. Doucette, C.L. Ryan, R.A. Tasker; Activation Of Kainate Receptor Signalling Systems In The Rat Pup: A New Model For Neurodevelopmental Disorders?; Abstract View, Program No. 81/6/Intinerary Planner, Wash. D.C. Society for Neuroscience, 2002/Online.
Tracey A. Doucette; Perinatal Administration of Kainate Receptor Agonists In The Rat: Immediate And Long-Term Behavioral Effects; Apr., 2003, Thesis Stanhope, P.E.I., University of Prince Edward Island.
Wolfgang Löscher, Dieter Schmidt; New horizons in the development of antiepileptic drugs; Epilepsy Research 50 (2002) 3-16.
Andrew J. Cole, Sookyong Koh and Yi Zheng; Are seizures harmful: what can we learn from animal models?; Progress in Brain Research, vol. 135 (2002) 13-23.
Todd A Verdoorn, Tina H. Johansen, Jorgen Drejer, Elsebet O. Nielsen; Selective block of recombinant glur6 receptors by NS-102, a novel non-NMDA receptor antagonist; European Journal of Pharmacology; Molecular Pharmacology Section 269 (1994) 43-49.
T.A. Doucette, S.M. Strain, G.V. Allen, C.L. Ryan, R.A.R. Tasker; Comparative behavioral toxicity of domoic acid and kainic acid in neonatal rats; Neurotoxicology and Teratology 22 (2000).
Robert K. McNamara and Ronald W. Skelton; The neuropharmacological and neurochemical basis of place learning in the Morris water maze; Brain Research Reveiws, 18 (1993) 33-49.
G. Jean Kant; Effects of Psychoactive Drugs or Stress on Learning, Memory, and Performance as Assessed Using a Novel Water Maze Task; Pharmacology Biochemistry and Behavior, vol. 44, (1993), 287-295.
Christine M. Gall; Seizure-Induced Changes In Neurotrophin Expression: Implications for Epilepsy; Experimental Neurology 124 (1993) 150-166.
Devin K. Binder, Susan D. Croll, Christine M. Gall and Helen EL. Scharfman; BDNF and epilepsy: too much of a good thing?; Trends in Neurosciences vol. 24 No. 1 Jan. 2001 pp. 47-53.
Makoto Takahashi, Shintaro Hayashi, Akiyoshi Kakita, Koichi Wakabayshi, Masafumi Fukuda, Shigeki Kameyama, Ryuichi Tanaka, Hitoshi Takahashi, Hiroyuki Nawa; Patients with temporal lobe epilepsy show an increase in brain-derived neurotrophic factor protein and its correlation with neuropeptide Y ; Brain Research 818 (1999) 579-582.
Bouchaib El Bahh, Romane Auvergne, Carole Leré Corinne Brana, Gildas Le Gal La Salle, Alain Rougier; Decreased epileptic susceptibility correlates with neuropeptide Y overexpression in a model of tolerance to excitotoxicity; Brain Research 894 (2001) 209-217.
A. Vezzani, T. Ravizza, D. Moneta, M. Conti, A Borroni, M. Rizzi, R. Samanin and R. Maj; Brain-Derived Neurotrophic Factor Immunoreactivity In The Limbic System Of Rats After Acute Seizures And During Spontaneous Convulsions: Temporal Evolution Of Changes As Compared To Neuropeptide Y; Neuroscience vol. 90; No. 4, pp. 1445-1461, 1999.
Cynthia Wetmore, Lars Olson, and Andrew J. Bean; Regulation of Brain-derived Neurotrophic Factor (BDNF) Expression and Release from Hippocampal Neurons Is Mediated by Non-NMDA Type Glutamate Receptors; The Journal of Neuroscience, Mar. 1994, 14(3): 1688-1700.
Q. Sun, S. Pretel, C.D. Applegate and D.T. Piekut; Oxytocin and Vasopressin mRNA Expression In Rat Hypothalamus Following Kainic Acid-Induced Seizures; Neuroscience vol. 71, No. 2, pp. 543-554, 1996.
D.T. Piekut, S. Pretel and C.D. Applegate; Activation of Oxytocin-Containing Neurons of the Paraventricular Nucleus (PVN) Following Generalized Seizures; SYNAPSE 23:312-320 (1996).
Daniela Jezova, Ivana Skultetyova, D.I. Tokarev, P. Bakos, and M. Vigas; Vasopressin and Oxytocin in Stress; 1995 Ann NY Acad. Sci. 771 pp. 192-203.
Yehezkel Ben-Ari and Rosa Cossart; Kainate, a double agent that generates seizures; two decades of progress; TINS vol. 23, No. 11, (2000) 580-587.
Carl E. Stafstrom, Antonia Chronopoulos, Samuel Thurber, James J. Thompson, and Gregory L. Holmes; Age-Dependent Cognitive and Behavioral Deficits After Kainic Acid Seizures; Epilepsia, 343(3): 420-432, 1993.
Carl E. Stafstrom, James L. Thompson and Gregory L. Holmes; Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures; Developmental Brain Research, 65 (1992) 227-236.
Ellen F. Sperber, Kurt Z. Haas, Patric K. Stanton, and Solomon L. Moshé ; Resistance of the immature hippocampus to seizure-induced synaptic reorganization; Developmental Brain Research, 60 (1991) 88-93.
Wolfgang Löscher; Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus moles of temporal lobe epilepsy; Epilepsy Research 50 (2002) 105-123.
Nancy Foldvary, Elain Wyllie; Goetz: Textbook of Clinical Neurology, 1sted.; Chapter 52—Epilepsy pp. 1-54 (1999).
Ikonomidou, Chrysanthy, Bittigau, Petra, Ishimaru, Masahiko J., Wozniak, David F., Koch, Christian, Genz, Kerstin, Price, Madelon T., Stefovska, Vanya, Horster, Friederike, Tenkova, Tanya, Dikranian, Krikor, Olney, John W.; Ethanol-Induced Apoptotic Neurodegeneration and Fetal Alcohol Syndrome; Science, 00368075, Feb. 11, 2000, vol. 287, Issue 5455 p. 1-8.
M.V. Johnston, J.W. McDonald, C.K. Chen, and W.H. Trescher; Role of Excitatory Amino Acid Receptors in Perinatal Hypoxic-Ischemic Brain Injury; Excitatory Amino Acids, edited by B.S. Medrum, F. Moroni, R.P. Simon, and J.H. Woods; 1991 pp. 711-716.
Elena Grigorenko, Steven Glazier, William Bell, Michal Tytell, Erin Nosel, Tim Pons, Sam A. Deadwyler; Changes in glutamate receptor subunit composition in hippocampus and cortex in patients with refractory epilepsy; Journal of Neurological Sciences 153 (1997) 35-45.
Albert E. Telfeian, Howard J. Federoff, Paola Leone, Matthew J. During, and Anne Williamson; Overexpression of GluR6 in Rat Hippocampus Produces Seizures and Spontaneous Nonsynaptic Bursting in Vitro; Neurobioglogy of Disease 7, 362-374 (2000).
Anne Bernard, Lotfi Ferhat, Frédédric Dessi, Géard Charton, Alfonso Represa, Yezekiel Ben-Ari and Michel Khrestchatisky; Q/R editing of the rat GluR5 and GluR6 kainate receptors in vivo and in vitro: evidence for independent developmental, pathological and cellular regulation; European Journal of Neuroscience, vol. 11, pp. 604-616, 1999.
Philip J. Larsen, Jens D. Mikkelsen, David S. Jess

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Developmental animal model of temporal lobe epilepsy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Developmental animal model of temporal lobe epilepsy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Developmental animal model of temporal lobe epilepsy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3612380

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.